BeeCure Secures $250K Investment, Partners with Capital Q Ventures
Deal News | Mar 12, 2025 | EIN
BeeCure, a leader in natural skincare solutions designed for radiation and laser treatment patients, has received a $250,000 investment from Capital Q Ventures. This partnership extends beyond funding to provide BeeCure with strategic resources and business advisory support aimed at accelerating the company's growth. The collaboration will focus on expanding BeeCure’s market presence, enhancing product development, and strengthening its industry leadership in therapeutic skincare solutions. Michael Quatrini, CEO of Capital Q Ventures, expressed confidence in BeeCure’s innovative approach to skincare and its potential to disrupt the market. The funds will support BeeCure’s strategies to enhance retail expansion, boost R&D for new product innovation, and cultivate partnerships with healthcare providers.
Sectors
- Skincare Industry
- Investment and Finance
Geography
- United States – BeeCure is based in Maitland, Florida, and the investment was made by US-based Capital Q Ventures.
Industry
- Skincare Industry – BeeCure operates in the skincare industry, providing natural treatments for patients undergoing radiation and laser therapies.
- Investment and Finance – Capital Q Ventures specializes in strategic investments in high-growth startups, representing the investment industry.
Financials
- $250,000 – The investment amount provided by Capital Q Ventures to BeeCure.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| BeeCure | Target | Company | A natural skincare company focused on radiation and laser treatment solutions. |
| Capital Q Ventures | Investor | Company | An investment firm specializing in early-stage and growth companies. |
| Michael Quatrini | CEO | Person | Chief Executive Officer of Capital Q Ventures. |
| Steve Weinstein | CEO | Person | Chief Executive Officer of BeeCure. |